These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 23095422
1. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations. Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D. Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422 [Abstract] [Full Text] [Related]
3. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A. Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808 [Abstract] [Full Text] [Related]
6. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV, Glatt SJ. J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220 [Abstract] [Full Text] [Related]
7. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Lachaine J, Beauchemin C, Sasane R, Hodgkins PS. Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908 [Abstract] [Full Text] [Related]
11. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
12. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands. Sasané R, Hodgkins P, Meijer W. Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165 [Abstract] [Full Text] [Related]
13. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults. Setyawan J, Hodgkins P, Guérin A, Gauthier G, Cloutier M, Wu E, Erder MH. J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642 [Abstract] [Full Text] [Related]
16. Factors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims data. Van Brunt DL, Johnston JA, Ye W, Pohl GM, O'Hara NN. J Manag Care Pharm; 2006 Apr; 12(3):230-8. PubMed ID: 16623607 [Abstract] [Full Text] [Related]
17. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. Childress AC. Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723 [Abstract] [Full Text] [Related]
18. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Gerhard T, Winterstein AG, Olfson M, Huang C, Saidi A, Crystal S. Pharmacoepidemiol Drug Saf; 2010 May; 19(5):457-64. PubMed ID: 20232490 [Abstract] [Full Text] [Related]